Literature DB >> 34132936

Prognostic factors for residual occult disease in shave margins during partial mastectomy.

Julie B Siegel1, Rupak Mukherjee2, Yeonhee Park3, Abbie R Cluver4, Catherine Chung2, David J Cole2, Mark A Lockett2, Nancy Klauber-DeMore2, Andrea M Abbott2.   

Abstract

PURPOSE: Shave margins have been shown to decrease positive final margins in partial mastectomy. We investigated prognostic factors associated with residual disease in shave margins.
METHODS: Patients with invasive breast carcinoma and ductal carcinoma in situ (DCIS) who had circumferential shave margins excised during lumpectomy were abstracted from a retrospective database from 2015 to 2018. We defined residual occult disease (ROD) as either (1) residual disease in a shave margin when the initial lumpectomy specimen had negative margins or (2) residual disease in a shave margin that did not correspond with the positive lumpectomy margin. We identified the frequency of ROD and conducted logistic regression analysis to identify associated prognostic factors.
RESULTS: 166 Patients (139 invasive carcinoma, 27 DCIS) were included with median follow-up of 28 months (9-50 months). Residual occult disease existed in 34 (24.5%) with invasive carcinoma and 8 (29.6%) with DCIS. In univariate analyses of the invasive group, invasive lobular carcinoma and a positive initial, non-corresponding lumpectomy margin were predictive of ROD (OR 3.63, p = 0.04, OR 3.48, p = 0.003 respectively). In multivariate analysis, a positive lumpectomy margin remained significant, p = 0.007. No variables were associated with ROD in DCIS.
CONCLUSION: Residual occult disease was shown to be a frequent event in this analysis of lumpectomy with circumferential shave margins. Having a positive initial lumpectomy margin was predictive of ROD in a non-corresponding margin. Surgeons should consider not being selective in their shave margins or margin of re-excision if shave margins were not obtained in their initial surgery.

Entities:  

Keywords:  Breast cancer; Lumpectomy; Partial mastectomy; Residual disease; Shave margins

Year:  2021        PMID: 34132936     DOI: 10.1007/s10549-021-06282-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  21 in total

1.  Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS.

Authors:  Carla S Fisher; V Suzanne Klimberg; Seema Khan; Feng Gao; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2011-09-27       Impact factor: 5.344

2.  Margin index: a new method for prediction of residual disease after breast-conserving surgery.

Authors:  Julie A Margenthaler; Feng Gao; V Suzanne Klimberg
Journal:  Ann Surg Oncol       Date:  2010-04-27       Impact factor: 5.344

3.  Circumferential Shaving of the Cavity in Breast-Conserving Surgery: A Randomized Controlled Trial.

Authors:  Kai Chen; Liling Zhu; Lili Chen; Qian Li; Shunrong Li; Na Qiu; Yaping Yang; Fengxi Su; Erwei Song
Journal:  Ann Surg Oncol       Date:  2019-08-19       Impact factor: 5.344

4.  Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.

Authors:  Laura H Rosenberger; Anita Mamtani; Sarah Fuzesi; Michelle Stempel; Anne Eaton; Monica Morrow; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2016-07-12       Impact factor: 5.344

5.  Close and Positive Lumpectomy Margins are Associated with Similar Rates of Residual Disease with Additional Surgery.

Authors:  Simon Fitzgerald; Anya Romanoff; Almog Cohen; Hank Schmidt; Christina Weltz; Ira J Bleiweis; Shabnam Jaffer; Elisa R Port
Journal:  Ann Surg Oncol       Date:  2016-08-31       Impact factor: 5.344

6.  A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer.

Authors:  Anees B Chagpar; Brigid K Killelea; Theodore N Tsangaris; Meghan Butler; Karen Stavris; Fangyong Li; Xiaopan Yao; Veerle Bossuyt; Malini Harigopal; Donald R Lannin; Lajos Pusztai; Nina R Horowitz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

7.  Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital.

Authors:  Veronica Jones; Jared Linebarger; Sebastian Perez; Sheryl Gabram; Joel Okoli; Harvey Bumpers; Brian Burns; Marina Mosunjac; Monica Rizzo
Journal:  Ann Surg Oncol       Date:  2015-08-08       Impact factor: 5.344

8.  Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.

Authors:  Meena S Moran; Stuart J Schnitt; Armando E Giuliano; Jay R Harris; Seema A Khan; Janet Horton; Suzanne Klimberg; Mariana Chavez-MacGregor; Gary Freedman; Nehmat Houssami; Peggy L Johnson; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2014-02-10       Impact factor: 5.344

9.  The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis.

Authors:  Nehmat Houssami; Petra Macaskill; M Luke Marinovich; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2014-01-29       Impact factor: 5.344

Review 10.  Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ.

Authors:  Monica Morrow; Kimberly J Van Zee; Lawrence J Solin; Nehmat Houssami; Mariana Chavez-MacGregor; Jay R Harris; Janet Horton; Shelley Hwang; Peggy L Johnson; M Luke Marinovich; Stuart J Schnitt; Irene Wapnir; Meena S Moran
Journal:  Ann Surg Oncol       Date:  2016-08-15       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.